Moderna (MRNA)

Financing Cash Flow

$590.00M

TTM · Period ending: · USD

MRNA logo

MRNA Financing Cash Flow

Latest reported$590.00M
MRNA TTM Cash from Financing ($168.00K → $590.00M)
High-resolution chart · PNG

MRNA financing cash flow history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Moderna Financing Cash Flow — Trailing twelve months (TTM) (USD)
Period endingFinancing Cash Flow (USD)
590,000,000
585,000,000
572,000,000
9,000,000
21,000,000
46,000,000
56,000,000
-50,000,000
-119,000,000
-821,000,000
-1,377,000,000
-1,706,000,000
-2,689,000,000
-3,348,000,000
-3,448,000,000
-3,883,000,000
-2,844,000,000
-1,541,000,000
-873,000,000
44,109,000
76,109,000
1,481,414,000
2,033,467,000
2,016,948,000
2,002,715,000
629,222,000
51,462,000
599,787,000
574,590,000
677,140,000
1,226,842,000
652,466,000
661,886,000
550,843,500
168,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.